Cognito Therapeutics Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 42

Employees

  • Latest Deal Type
  • Series C

  • Latest Deal Amount
  • $110M

  • Investors
  • 12

Cognito Therapeutics General Information

Description

Developer of digital therapeutics designed to treat neurodegenerative disorders by modulating brain activity and targeting underlying disease mechanisms associated with cognitive decline. The company offers therapies that induce specific brain wave oscillations through non-invasive stimulation, modulate neural activity, and activate immune responses in the brain to target amyloid plaques and tau tangles, enabling patients with neurodegenerative disorders to address disease progression and support cognitive function.

Contact Information

Website
www.cognitotx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 55 Cambridge Parkway
  • Suite 102W
  • Cambridge, MA 02142
  • United States
+1 (857)
Primary Industry
Therapeutic Devices
Vertical(s)
Nanotechnology, Digital Health, Wearables & Quantified Self, HealthTech, Life Sciences
Corporate Office
  • 55 Cambridge Parkway
  • Suite 102W
  • Cambridge, MA 02142
  • United States
+1 (857)

Cognito Therapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cognito Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series C) 05-Mar-2026 $110M Completed Pre-Clinical Trials
3. Later Stage VC (Series C) 02-Jul-2024 Completed Clinical Trials - Phase 3
2. Later Stage VC (Series B) 15-Nov-2023 $129M $149M Completed Clinical Trials - Phase 3
1. Early Stage VC (Series A) 18-Jul-2016 $20M $20M Completed Pre-Clinical Trials
To view Cognito Therapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Cognito Therapeutics Patents

  • 90

    Total Documents Applications and Grants

  • Total Patents Families

  • 27

    Granted

  • 43

    Pending

  • Expiring in next 12 mo

Cognito Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026236314-A1 Systems, devices, kits, and methods for targeted gamma oscillations Pending 07-May-2025
EP-4836722-A1 Devices and systems for neural, visual, auditory, or haptic stimulation and methods of using the same Pending 03-Jan-2025
WO-2026090239-A1 Devices and systems for neural, visual, auditory, or haptic stimulation and methods of using the same Pending 23-Oct-2024
WO-2026030535-A1 Wireless audio and haptic devices and systems for neural stimulation and methods of using the same Pending 01-Aug-2024
US-D1146891-S1 Base station for a single headset Active 05-Jan-2024
To view Cognito Therapeutics’s complete patent history, request access »

Cognito Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cognito Therapeutics Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Apollo Health Ventures Venture Capital Minority
Benvolio Group Venture Capital Minority
Hercules Capital BDC Business Development Company Minority
New Vintage Family Office Minority
MicroVentures Venture Capital Minority
You’re viewing 5 of 12 investors. Get the full list »

Ready to get started?

Request a free trial

Cognito Therapeutics FAQs

  • When was Cognito Therapeutics founded?

    Cognito Therapeutics was founded in 2016.

  • Where is Cognito Therapeutics headquartered?

    Cognito Therapeutics is headquartered in Cambridge, MA.

  • What is the size of Cognito Therapeutics?

    Cognito Therapeutics has 42 total employees.

  • What industry is Cognito Therapeutics in?

    Cognito Therapeutics’s primary industry is Therapeutic Devices.

  • Is Cognito Therapeutics a private or public company?

    Cognito Therapeutics is a Private company.

  • What is Cognito Therapeutics’s current revenue?

    The current revenue for Cognito Therapeutics is .

  • How much funding has Cognito Therapeutics raised over time?

    Cognito Therapeutics has raised $269M.

  • Who are Cognito Therapeutics’s investors?

    Apollo Health Ventures, Benvolio Group, Hercules Capital BDC, New Vintage, and MicroVentures are 5 of 12 investors who have invested in Cognito Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process